William Summerlin

Last updated

William Summerlin
Born
William T. Summerlin
Occupation(s) dermatologist, medical researcher
Known forperpetrated scientific fraud

William T. Summerlin (born 1938) is a dermatologist and medical researcher who engaged in scientific fraud involving his claims of successful skin transplantation without immunosuppression. Scientists were unable to replicate Summerlin's results, which drew scrutiny. A lab assistant noticed that one of the white lab mice that was supposed to have a dark patch of skin successfully grafted onto it had fur that was colored with ink from a felt-tip pen. An investigation of Summerlin's research ultimately led to the termination of his employment at Memorial Sloan-Kettering Cancer Center.

Contents

The New York Times called this a "medical Watergate", and the Los Angeles Times wrote it was one of the most "notable example(s) of fraudulent scientific research". The phrase "painting the mice" became synonymous with research fraud.

Career

Summerlin began working at Stanford University in 1967, transferred to the University of Minnesota in 1973 and to Memorial Sloan-Kettering Cancer Center by 1974. [1]

At a 1969 conference of dermatologists, Summerlin announced that eight patients at Stanford University successfully received skin grafts grown from cells in test tubes over six weeks old. [2]

In 1973 from the University of Minnesota, Summerlin announced that he had managed to change cell surfaces by soaking the tissue that needed to be transplanted in a common nutrient liquid allowing the tissue to be grafted to the host without triggering any rejection mechanisms, this would be used for burns and scars. "This means 'one of the most significant - even revolutionary - advances (in transplant research)' may be just beyond the horizon" according to an editor from the Journal of the American Medical Association. [3] This new technique aimed to avoid using anti-rejection drugs which can make patients more susceptible to infections. The hope according to Summerlin is to be able to avoid rejections from transplanted organs like hearts and kidneys, the problem is that the transplanted tissue needs to sit for six weeks in the solution before transplant, at this time a heart or kidney could only survive a couple days outside of the body. But Summerlin and his advisor immunologist Robert A. Good hoped that machines would be soon invented that allowed organs to last the six weeks needed for them to soak. According to Good "the potential is fantastic". [4]

Speaking at an American Cancer Society seminar in Nogales, Arizona in March 1973, Summerlin summarized that currently doctors have to replace skin on a burn victim "bit by bit" in order to avoid tissue rejection. Potentially with Summerlin's discovery, doctors would have "skin stored in sheets" grown from donor cells to be used quickly to repair burns. [5]

Investigation and repercussions

In 1970, working as a clinical researcher at Stanford University, Summerlin announced that he had been able to transplant skin from one unrelated person to another, avoiding the normal issues of transplant rejection. Other researchers were unable to duplicate the results. [6] In 1973 he transferred to the University of Minnesota where he announced that he had transplanted the skin from a black man to a white man successfully. Again, scientists were unable to confirm this happening. [7]

In 1974, Summerlin was working under Good at Memorial Sloan-Kettering Cancer Center in New York City, conducting research in transplantation immunology, when Good asked Summerlin to repeat the success Summerlin had had with human skin grafting to replicate using mice. Good asked research fellow, John Ninnemann to replicate Summerlin's experiments but Ninnemann was unsuccessful. [1] Accusations from colleagues surfaced that Summerlin had not been successful with his transplants, but instead was faking the results by using a black pen to color the skin on the mouse. [6] A research assistant looking at the mouse discovered that the darkened patch could be removed with alcohol. [8]

A five-person committee led by C. Chester Stock commissioned a report which was released at the cancer center stating that Summerlin had admitted "to the committee that he had darkened the skin of two white mice with a felt-tip pen to make it appear that the mice had accepted skin grafts from genetically different animals, and that on four occasions he had misrepresented the results of experimental transplants of human corneas into rabbit eyes. The committee concluded that Summerlin's actions represented “irresponsible conduct that is incompatible with discharge of his responsibilities in the scientific community.” A mouse from the research at the University of Minnesota was found to have successful skin grafts, but it was later discovered that the mouse was very closely related to the mouse it had received the skin from, thus making it not out of the norm of what would have been expected. [1]

Memorial Sloan-Kettering President Lewis Thomas said that Summerlin was suffering from a "serious emotional disturbance". [1] "He has not been fully responsible for the actions he has taken nor the representations he has made" according to Thomas. [9]

The committee's report also concluded that Summerlin's advisor, Good, was at fault for not fully vetting Summerlin before hiring him, being slow to take claims of sloppy research seriously, and for being overly supportive of successful claims made by Summerlin without collaborating evidence. Good's response was, "that the affair had made him 'a ‐somewhat wiser and sadder person' who, in the future, would be more skeptical about the purported findings of the many scientists working under him". [1]

According to Newsday science writer, David Zinman, cancer research funding may be to blame, congress doubled the budget from $233 million in 1971 to $589 million in 1974. This caused fierce competition for the money and an "early release of data on promising experiments in the hope of attracting recognition and more money". National Cancer Institute Doctor William Terry says that blaming funding is no excuse for scientific hoaxes, there has always been competition and egos involved. [10]

Aftermath

The Memorial Sloan-Kettering Cancer Center committee recommended that Summerlin be fired from his job, but voted to allow him a year of paid medical leave in order for him to receive medical care and rest first. [9]

The New York Times called this scandal "a medical Watergate that reflected dangerous trends in current efforts to gain scientific acclaim and funds for research.” Good was accused of hyping Summerlin's research accomplishments for financial gain of the cancer center. [1]

A 1987 Los Angeles Times article called the thirteen-year-old case one of the most "notable example(s) of fraudulent scientific research". [11]

The phrase "painting the mice" has become synonymous with research fraud. [12] [13] [14]

See also

Related Research Articles

Histocompatibility, or tissue compatibility, is the property of having the same, or sufficiently similar, alleles of a set of genes called human leukocyte antigens (HLA), or major histocompatibility complex (MHC). Each individual expresses many unique HLA proteins on the surface of their cells, which signal to the immune system whether a cell is part of the self or an invading organism. T cells recognize foreign HLA molecules and trigger an immune response to destroy the foreign cells. Histocompatibility testing is most relevant for topics related to whole organ, tissue, or stem cell transplants, where the similarity or difference between the donor's HLA alleles and the recipient's triggers the immune system to reject the transplant. The wide variety of potential HLA alleles lead to unique combinations in individuals and make matching difficult.

<span class="mw-page-title-main">Organ transplantation</span> Medical procedure in which an organ is removed from one body and placed in the body of a recipient

Organ transplantation is a medical procedure in which an organ is removed from one body and placed in the body of a recipient, to replace a damaged or missing organ. The donor and recipient may be at the same location, or organs may be transported from a donor site to another location. Organs and/or tissues that are transplanted within the same person's body are called autografts. Transplants that are recently performed between two subjects of the same species are called allografts. Allografts can either be from a living or cadaveric source.

<span class="mw-page-title-main">Peter Medawar</span> Brazilian-British biologist (1915–1987)

Sir Peter Brian Medawar was a Brazilian-British biologist and writer, whose works on graft rejection and the discovery of acquired immune tolerance have been fundamental to the medical practice of tissue and organ transplants. For his scientific works, he is regarded as the "father of transplantation". He is remembered for his wit both in person and in popular writings. Richard Dawkins referred to him as "the wittiest of all scientific writers"; Stephen Jay Gould as "the cleverest man I have ever known".

<span class="mw-page-title-main">Skin grafting</span> Surgical transplantation of skin

Skin grafting, a type of graft surgery, involves the transplantation of skin. The transplanted tissue is called a skin graft.

<span class="mw-page-title-main">Xenotransplantation</span> Transplantation of cells or tissue across species

Xenotransplantation, or heterologous transplant, is the transplantation of living cells, tissues or organs from one species to another. Such cells, tissues or organs are called xenografts or xenotransplants. It is contrasted with allotransplantation, syngeneic transplantation or isotransplantation and autotransplantation. Xenotransplantation is an artificial method of creating an animal-human chimera, that is, a human with a subset of animal cells. In contrast, an individual where each cell contains genetic material from a human and an animal is called a human–animal hybrid.

Allotransplant is the transplantation of cells, tissues, or organs to a recipient from a genetically non-identical donor of the same species. The transplant is called an allograft, allogeneic transplant, or homograft. Most human tissue and organ transplants are allografts.

<span class="mw-page-title-main">Memorial Sloan Kettering Cancer Center</span> Hospital in New York City, founded 1884

Memorial Sloan Kettering Cancer Center is a cancer treatment and research institution in Manhattan in New York City. It was founded in 1884 as the New York Cancer Hospital. MSKCC is one of 72 National Cancer Institute-designated Comprehensive Cancer Centers. It had already been renamed and relocated, to its present site, when the Sloan-Kettering Institute for Cancer Research was founded in 1945, and built adjacent to the hospital. The two medical entities formally coordinated their operations in 1960, and formally merged as a single entity in 1980. Its main campus is located at 1275 York Avenue between 67th and 68th Streets in Manhattan.

<span class="mw-page-title-main">C. C. Little</span> American geneticist

Clarence Cook Little was an American genetics, cancer, and tobacco researcher and academic administrator, as well as a proponent of eugenics.

<span class="mw-page-title-main">Michael Woodruff</span> English surgeon and biologist; transplantation and cancer researcher (1911–2001)

Sir Michael Francis Addison Woodruff, was an English surgeon and scientist principally remembered for his research into organ transplantation. Though born in London, Woodruff spent his youth in Australia, where he earned degrees in electrical engineering and medicine. Having completed his studies shortly after the outbreak of World War II, he joined the Australian Army Medical Corps, but was soon captured by Japanese forces and imprisoned in the Changi Prison Camp. While there, he devised an ingenious method of extracting nutrients from agricultural wastes to prevent malnutrition among his fellow POWs.

<span class="mw-page-title-main">Robert A. Good</span> American physician

Robert Alan Good NAM, NAS, AAAS was an American physician who performed the first successful human bone marrow transplant between persons who were not identical twins. He is regarded as a founder of modern immunology.

<span class="mw-page-title-main">Lloyd J. Old</span> 20th-century American immunology researcher

Lloyd John Old was one of the founders and standard-bearers of the field of cancer immunology. When Old began his career in 1958, tumor immunology was in its infancy. Today, cancer immunotherapies are emerging as a significant advance in cancer therapy.

Human leukocyte antigens (HLA) began as a list of antigens identified as a result of transplant rejection. The antigens were initially identified by categorizing and performing massive statistical analyses on interactions between blood types. This process is based upon the principle of serotypes. HLA are not typical antigens, like those found on surface of infectious agents. HLAs are alloantigens, they vary from individual to individual as a result of genetic differences. An organ called the thymus is responsible for ensuring that any T-cells that attack self proteins are not allowed to live. In essence, every individual's immune system is tuned to the specific set of HLA and self proteins produced by that individual; where this goes awry is when tissues are transferred to another person. Since individuals almost always have different "banks" of HLAs, the immune system of the recipient recognizes the transplanted tissue as non-self and destroys the foreign tissue, leading to transplant rejection. It was through the realization of this that HLAs were discovered.

Transplantable organs and tissues may refer to both organs and tissues that are relatively often transplanted, as well as organs and tissues which are relatively seldom transplanted. In addition to this it may also refer to possible-transplants which are still in the experimental stage.

John Joseph Bittner was a geneticist and cancer biologist, who made many contributions on the genetics of breast cancer research, which were of value, not only in cancer research, but also in a variety of other biological investigations.

<span class="mw-page-title-main">Beatrice Mintz</span> American biologist (1921–2022)

Beatrice Mintz was an American embryologist who contributed to the understanding of genetic modification, cellular differentiation, and cancer, particularly melanoma. Mintz was a pioneer of genetic engineering techniques and was among the first scientists to generate both chimeric and transgenic mammals.

In tissue engineering, neo-organ is the final structure of a procedure based on transplantation consisting of endogenous stem/progenitor cells grown ex vivo within predesigned matrix scaffolds. Current organ donation faces the problems of patients waiting to match for an organ and the possible risk of the patient's body rejecting the organ. Neo-organs are being researched as a solution to those problems with organ donation. Suitable methods for creating neo-organs are still under development. One experimental method is using adult stem cells, which use the patients own stem cells for organ donation. Currently this method can be combined with decellularization, which uses a donor organ for structural support but removes the donors cells from the organ. Similarly, the concept of 3-D bioprinting organs has shown experimental success in printing bioink layers that mimic the layer of organ tissues. However, these bioinks do not provide structural support like a donor organ. Current methods of clinically successful neo-organs use a combination of decellularized donor organs, along with adult stem cells of the organ recipient to account for both the structural support of a donor organ and the personalization of the organ for each individual patient to reduce the chance of rejection.

<span class="mw-page-title-main">Georges Mathé</span> French oncologist and immunologist (1922–2010)

Georges Mathé was a French oncologist and immunologist. In November 1958, he performed the first successful allogeneic bone marrow transplant ever performed on unrelated human beings.

Patient derived xenografts (PDX) are models of cancer where the tissue or cells from a patient's tumor are implanted into an immunodeficient or humanized mouse. It is a form of xenotransplantation. PDX models are used to create an environment that allows for the continued growth of cancer after its removal from a patient. In this way, tumor growth can be monitored in the laboratory, including in response to potential therapeutic options. Cohorts of PDX models can be used to determine the therapeutic efficiency of a therapy against particular types of cancer, or a PDX model from a specific patient can be tested against a range of therapies in a 'personalized oncology' approach.

Marcel R.M. van den Brink is a Dutch oncologist and researcher at Memorial Sloan Kettering Cancer Center known for his research in hematopoietic stem cell transplantation for cancer patients.

Lorenz Studer is a Swiss biologist. He is the founder and director of the Center for Stem Cell Biology at Memorial-Sloan Kettering Cancer Center in New York City. He is a developmental biologist and neuroscientist who is pioneering the generation of midbrain dopamine neurons for transplantation and clinical applications. His expertise in cell engineering spans a wide range of cells/tissues within the nervous system geared toward disease modeling and exploring cell replacement therapy. Currently, he is a member of the Developmental Biology Program and Department of Neurosurgery at Memorial Sloan-Kettering Cancer Center and a Professor of Neuroscience at Weill Cornell Medical College in New York City, NY.

References

  1. 1 2 3 4 5 6 Brody, Jane E. (May 25, 1974). "Inquiry at Cancer Center Finds Fraud in Research". The New York Times . p. 61. Retrieved March 9, 2022.
  2. ↑ "Test-Tube Skin at Stanford Spurs Normal Tissue Growth Growth". The Sacramento Bee. July 12, 1969. p. 1. Retrieved March 9, 2022.
  3. ↑ Cope, Lewis (January 17, 1973). "Million Dollar Goal is Set for Hospital HereDoctor develops new transplant technique at 'U'". Star Tribune. p. 1. Retrieved March 9, 2022.
  4. ↑ Cope, Lewis (January 17, 1973). "Doctor develops new transplant technique at 'U'". Star Tribune. p. 3. Retrieved March 9, 2022.
  5. ↑ Edelson, Edward (March 31, 1973). "Relief for Burn Victims Seen in Cultured Skin". Daily News. p. 162. Retrieved March 9, 2022.
  6. 1 2 "Medicine: The S.K.I. Affair". time.com. Time Magazine. June 3, 1974. Archived from the original on October 26, 2012. Retrieved March 10, 2022.
  7. ↑ "Skin Deep - review of book The Patchwork Mouse". time.com. Time Magazine. March 8, 1976. Archived from the original on October 26, 2012. Retrieved March 10, 2022.
  8. ↑ Weissmann, Gerald (April 1, 2006). "Science fraud: from patchwork mouse to patchwork data". The FASEB Journal. Faseb Journal. 20 (6): 587–590. doi:10.1096/fj.06-0401ufm. PMID   16581962. S2CID   25604615 . Retrieved March 9, 2022.
  9. 1 2 Auerbach, Stuart (May 25, 1974). "Scientist Accused Of Faking Results Of Skin Graft Test". The Miami Herald. p. 15. Retrieved March 9, 2022.
  10. ↑ Zinman, David (April 29, 1974). "Did research race provoke a hoax?". Newsday. p. 91. Retrieved March 9, 2022.
  11. ↑ Steinbrook, Robert (April 29, 1987). "Research Increase in Biomedical Fakery Triggers Debate". LA Times. p. 9. Retrieved March 9, 2022.
  12. ↑ Lawson, Gerald (October 30, 2017). "Painting the mice: research fraud". www.ogmagazine.org.au/. OG Magazine. Retrieved March 9, 2022.
  13. ↑ Whitbeck, Carolyn (1995). "Truth and Trustworthiness in Research". Science and Engineering Ethics. Online Ethics Center. 1 (4): 403–416. doi:10.1007/BF02583258. PMID   11657785. S2CID   28294954. Archived from the original on February 14, 2008. Retrieved March 9, 2022.
  14. ↑ "Research Misconduct" (PDF). www.uidaho.edu. University of Idaho. p. 2. Retrieved March 9, 2022.

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.